Business Description
LSL Pharma Group Inc
NAICS : 325410
SIC : 3741
ISIN : CA50190N1042
Share Class Description:
TSXV:LSL: Class ATotal Employee Number:
245Description
LSL Pharma Group Inc develops, manufactures and commercializes sterile pharmaceutical products, cosmetic products and natural health products. It operates in three segments CMO activities include four operating entities LSL Laboratory, Dermolab, Du-Var, and VSI; Integrated Eye-care pharmaceutical company which includes sterile Eye-care manufacturing operation; and Private Label Business includes Juno OTC which commercializes pharmaceutical products with a focus on private label, over the counter (OTC) products. It derives majority of revenue from CMO activities segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.81 | |||||
Debt-to-EBITDA | 122.39 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 0.5 | |||||
Beneish M-Score | -1.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.6 | |||||
3-Year EPS without NRI Growth Rate | 26.7 | |||||
3-Year FCF Growth Rate | -7.3 | |||||
3-Year Book Growth Rate | 49.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.4 | |||||
9-Day RSI | 49.49 | |||||
14-Day RSI | 47.16 | |||||
3-1 Month Momentum % | -19.51 | |||||
6-1 Month Momentum % | -24.14 | |||||
12-1 Month Momentum % | -17.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.33 | |||||
Quick Ratio | 0.45 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 159.81 | |||||
Days Sales Outstanding | 59.74 | |||||
Days Payable | 53.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.5 | |||||
Shareholder Yield % | -40.91 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 10.94 | |||||
Operating Margin % | -13.3 | |||||
Net Margin % | -15.93 | |||||
EBITDA Margin % | 1.04 | |||||
FCF Margin % | -30.98 | |||||
OCF Margin % | -15.98 | |||||
ROE % | -21.81 | |||||
ROA % | -8.24 | |||||
ROIC % | -7.7 | |||||
3-Year ROIIC % | 11.38 | |||||
ROC (Joel Greenblatt) % | -5.9 | |||||
ROCE % | -4.86 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.13 | |||||
PB Ratio | 1.68 | |||||
Price-to-Tangible-Book | 16 | |||||
EV-to-EBIT | -33.15 | |||||
EV-to-EBITDA | 233.83 | |||||
EV-to-Revenue | 2.43 | |||||
EV-to-FCF | -7.83 | |||||
Price-to-GF-Value | 0.44 | |||||
Earnings Yield (Greenblatt) % | -3.02 | |||||
FCF Yield % | -26.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
LSL Pharma Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 34.419 | ||
| EPS (TTM) (C$) | -0.03 | ||
| Beta | -0.4562 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.17 | ||
| Volatility % | 62.36 | ||
| 14-Day RSI | 47.16 | ||
| 14-Day ATR (C$) | 0.011149 | ||
| 20-Day SMA (C$) | 0.317 | ||
| 12-1 Month Momentum % | -17.5 | ||
| 52-Week Range (C$) | 0.3 - 0.56 | ||
| Shares Outstanding (Mil) | 126.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
LSL Pharma Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
LSL Pharma Group Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
LSL Pharma Group Inc Frequently Asked Questions
What is LSL Pharma Group Inc(TSXV:LSL)'s stock price today?
The current price of TSXV:LSL is C$0.32. The 52 week high of TSXV:LSL is C$0.56 and 52 week low is C$0.30.
When is next earnings date of LSL Pharma Group Inc(TSXV:LSL)?
The next earnings date of LSL Pharma Group Inc(TSXV:LSL) is .
Does LSL Pharma Group Inc(TSXV:LSL) pay dividends? If so, how much?
LSL Pharma Group Inc(TSXV:LSL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on LSL Pharma Group Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers